Correlation Between Allovir and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Allovir and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allovir and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Allovir and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and Anebulo Pharmaceuticals.
Diversification Opportunities for Allovir and Anebulo Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Allovir and Anebulo is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Allovir i.e., Allovir and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Allovir and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Allovir is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Allovir is 1.04 times less risky than Anebulo Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 299.00 in Anebulo Pharmaceuticals on August 27, 2024 and sell it today you would lose (159.00) from holding Anebulo Pharmaceuticals or give up 53.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allovir vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Allovir |
| Anebulo Pharmaceuticals |
Allovir and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allovir and Anebulo Pharmaceuticals
The main advantage of trading using opposite Allovir and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Allovir vs. Anebulo Pharmaceuticals | Allovir vs. Mineralys Therapeutics, Common | Allovir vs. AN2 Therapeutics | Allovir vs. Aerovate Therapeutics |
| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |